ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+24.49%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.89B
AUM Growth
+$2.89B
(+25%)
Cap. Flow
+$364M
Cap. Flow
% of AUM
12.6%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
38
New
5
Increased
11
Reduced
4
Closed
3
Top Buys
| 1 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$91.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$85.2M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$45.6M |
| 4 |
Adverum Biotechnologies
ADVM
|
$41.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$31.1M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$23.2M |
| 2 |
Assembly Biosciences
ASMB
|
$17.7M |
| 3 |
Establishment Labs
ESTA
|
$11.4M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$9.7M |
| 5 |
Indaptus Therapeutics
INDP
|
$7.29M |
Sector Composition
| 1 | Healthcare | 88.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pacira BioSciences
PCRX
$1.2B
| $17.4M | 0.6% |
400,000
| – | – |
|
27
Adaptive Biotechnologies
ADPT
$2.01B
| $9.66M | 0.33% |
+200,000
| New | +$9.66M |
|
28
Kodiak Sciences
KOD
$478M
| $6.75M | 0.23% |
577,021
-50,000
| -8% | -$585K |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| $5.55M | 0.19% |
6,240,000
| – | – |
|
30
Fennec Pharmaceuticals
FENC
$247M
| $4.42M | 0.15% |
1,105,999
| – | – |
|
31
Rocket Pharmaceuticals
RCKT
$354M
| $4.29M | 0.15% |
+285,714
| New | +$4.29M |
|
|
32
Indaptus Therapeutics
INDP
$6.81M
| $3.56M | 0.12% |
820,000
-1,680,000
| -67% | -$7.29M |
|
|
TLGT
33
DELISTED
Teligent, Inc
TLGT
| $3.3M | 0.11% |
5,231,206
| – | – |
|
|
34
Assembly Biosciences
ASMB
$190M
| – | – |
-900,000
| Closed | -$17.7M |
|
|
35
Establishment Labs
ESTA
$1.2B
| – | – |
-475,000
| Closed | -$11.4M |
|
36
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
37
Outlook Therapeutics
OTLK
$38.6M
| – | – |
-84,999
| Closed | -$630K |
|
38
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
0
| – | – |
|